Scotiabank Reaffirms Outperform Rating for Trilogy International Partners (TRL)
Trilogy International Partners (TSE:TRL)‘s stock had its “outperform” rating reissued by equities researchers at Scotiabank in a research report issued to clients and investors on Thursday. They presently have a C$9.50 price objective on the specialty pharmaceutical company’s stock. Scotiabank’s target price would indicate a potential upside of 80.27% from the stock’s current price.
TRL has been the topic of several other research reports. TD Securities cut shares of Trilogy International Partners from a “buy” rating to a “hold” rating and lowered their target price for the company from C$9.50 to C$7.00 in a research note on Friday, November 10th. Royal Bank Of Canada raised their target price on shares of Trilogy International Partners from C$9.00 to C$11.00 and gave the company an “outperform” rating in a research note on Monday, November 13th.
Trilogy International Partners (TRL) traded up C$0.02 during trading on Thursday, reaching C$5.27. 71,500 shares of the company’s stock traded hands, compared to its average volume of 43,454. Trilogy International Partners has a 52-week low of C$5.19 and a 52-week high of C$10.02.
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.
Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with MarketBeat.com's FREE daily email newsletter.